Adolf Hitler: My Parts Per Million in his Downfall

In his novel, Adolf Hitler: My Part in His Downfall, Spike Milligan describes waiting for the train to take him to his first military posting during WWII. His commanding officer hands him a picture of Hitler labeled: This is your enemy. "I searched every compartment," writes Milligan, "but he wasn't on the train." In a way, we are still searching for the Führer. Hitler is the archetypal enemy, whose badness virtually all can agree on, which is why his name often crops up in discussions

Written byStuart Blackman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In his novel, Adolf Hitler: My Part in His Downfall, Spike Milligan describes waiting for the train to take him to his first military posting during WWII. His commanding officer hands him a picture of Hitler labeled: This is your enemy. "I searched every compartment," writes Milligan, "but he wasn't on the train."

In a way, we are still searching for the Führer. Hitler is the archetypal enemy, whose badness virtually all can agree on, which is why his name often crops up in discussions about contemporary world leaders. Opponents of Saddam Hussein, Ariel Sharon, and Robert Mugabe have drawn comparisons between their respective nemeses and the Führer. It is a forceful, albeit lazy, way to clarify the muddy moral waters of modern international politics.

The same argumentative tactic is used in discussions surrounding other tricky issues. Since starring as the lead villain in Rachel Carson's seminal environmentalist text, Silent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies